Who will takeover animated Batman’s voice after Kevin Conroy? Here’s what we know
Batman voice actor Kevin Conroy passed away last week after a fight with cancer. Some have gone so far as to say the character's voice is now gone. In the future, things may change in order to better connect with projects in TV, live action, and g...
By ET Spotlight Special |
Agencies
Kevin Conroy is best known for portraying Bruce Wayne, or Batman, in the animated version since the 1990s. Conroy gave voice to the superhero for decades, and it would be a void hard to fill as the masses now identify that voice with Batman.
The voice actor passed away on November 10 in his fight against cancer. People identify his voice as that of Batman in the animated series, and that would be hard to replace. People think Batman’s voice is gone forever, but the show must go on. Many people have donned the mantle of Batman over time, but Conroy was the most sought-after. To begin, there are numerous formats available, such as gaming, animation, and movies. Peter Safran, the producer, and James Gunn, the director, have been considered a phenomenal pair since they joined Warner Brothers. They are expected to go far in their quest to tell more stories about Batman, including in the gaming arena. A Conroy soundalike would be sought to maintain consistency, which could help Batman continue to have his voice.
Market trading guide: Zydus Lifesciences among 4 stock recommendations for Monday
1/5
During the holiday-shortened week, Nifty ended at close to 17,800 points while Nifty Bank saw some pressure on the final session of the week and ended lower by 0.75%. “The coming week might conclude a road map for the markets till Dec 2022 since we have a mega event of the US Fed. In addition; RBI has scheduled additional MPC meeting on Nov 03, 2022,” said Mehul Kothari - AVP- Technical Research, Anand Rathi Shares & Stock Brokers.
Here are stock 4 recommendations for Monday:
During the holiday-shortened week, Nifty ended at close to 17,800 points while Nifty Bank saw some pressure on the final session of the week and ended lower by 0.75%. “The coming week might conclude ..
Read More
Buy near Rs 610 Target: Rs 645 Stop loss: Rs 590
On the daily scale; we are witnessing a trend line breakout above Rs 605. This breakout also resembles a bullish inverse head and shoulder pattern.
Buy near Rs 610Target: Rs 645Stop loss: Rs 590On the daily scale; we are witnessing a trend line breakout above Rs 605. This breakout also resembles a bullish inverse head and shoulder pattern.(Mehu..
Read More
Buy near Rs 236 Target: Rs 260 Stop loss: Rs 224
For the last three months; the stock has been trading in a band of Rs 238 - 208. During the last session, it confirmed a range breakout above Rs 238 along with decent volumes.
Buy near Rs 236Target: Rs 260Stop loss: Rs 224For the last three months; the stock has been trading in a band of Rs 238 - 208. During the last session, it confirmed a range breakout above Rs 238 alon..
Zydus Lifesciences found support around the Rs 319 levels in May, which also roughly coincides with previous intermediate lows of the stock. The stock has subsequently risen and made higher bottoms in the last few months.
In the process, the stock has broken out of a tight range. Momentum readings like the 14-week RSI, too, are in rising mode and not overbought, which is encouraging.
With the intermediate technical setup too looking positive, we believe the stock has the potential to move higher in the coming weeks.
(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)
Buying range: Rs 426-432Target price: Rs 470Stop loss: Rs 408Zydus Lifesciences found support around the Rs 319 levels in May, which also roughly coincides with previous intermediate lows of the stoc..
Divis Lab is in a short-term downtrend as it has been making lower tops and lower bottoms for the last few weeks. On Friday, the stock broke the recent support of Rs 3,562, indicating the downtrend looks set to continue.
Technical indicators are giving negative signals as the stock is now trading below the 20-day and 50-day SMA. Momentum readings like the 14-day RSI are in decline mode, which implies potential for more downsides.
We therefore expect the stock to correct further in the coming sessions.
(Subash Gangadharan, Senior Technical and Derivative Analyst, HDFC Securities)
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Selling range-Rs 3,540-3,550 levels.Downside target: Rs 3,400Stop loss- Rs 3,640Divis Lab is in a short-term downtrend as it has been making lower tops and lower bottoms for the last few weeks. On Fr..
Conroy was born in New York, and Juilliard School’s drama division shared rooms with Robin Williams. He did come across as a gay man, and he had to lose a lot of work in the bargain. Rino Romano, the Canadian actor, has been doing a lot of work on Batman lately, and he is likely to get an opportunity to carry on the legacy of Conroy.
FAQs:
What did Conroy die of? Intestinal Cancer.
Name the award he won in 2015. Consider Legit's Best for Best Actor.